Murray Stahl's CRL Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 0 shares of Charles River Laboratories International, Inc. (CRL) worth $0, representing 0.00% of the portfolio. First purchased in , this recently established position has been held for 0 quarters.
Based on recent 13F filings, Murray Stahl has initiated a new position in CRL, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2021, adding 75,962 shares. Largest reduction occurred in Q4 2024, reducing 54,922 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| No data available | ||||
Murray Stahl's Charles River Laboratories International Investment FAQs
According to the latest 13F filing for Q3 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 12,909 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $2.02 M.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.02% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Charles River Laboratories International, Inc. (CRL) was 298,974 shares, as reported at the end of Q2 2022.